HEPATIC CANCER
Clinical trials for HEPATIC CANCER explained in plain language.
Never miss a new study
Get alerted when new HEPATIC CANCER trials appear
Sign up with your email to follow new studies for HEPATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug EXS74539 targets tough cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new drug called EXS74539 in about 40 adults with advanced solid tumors, including lung, prostate, ovarian, and breast cancers. The main goal is to find a safe dose and check for side effects. Researchers will also watch for signs that the drug shrin…
Matched conditions: HEPATIC CANCER
Phase: PHASE1 • Sponsor: Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 07, 2026 18:38 UTC
-
Blood test breakthrough: AI-Powered exosome analysis could end liver cancer guesswork
Diagnosis Recruiting nowThis study aims to develop a blood test that uses tiny particles called exosomes and machine learning to help doctors accurately tell apart two common types of liver cancer—hepatocellular carcinoma and cholangiocarcinoma—before surgery. Researchers will collect blood samples from…
Matched conditions: HEPATIC CANCER
Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated May 13, 2026 16:00 UTC
-
New study aims to find best pain relief for cancer surgery patients
Symptom relief Recruiting nowThis study tests three common pain management methods used during minimally invasive cancer surgery. About 48 adults having surgery for cancers like liver, stomach, or colorectal cancer will be randomly assigned to one of three groups: a nerve block with numbing medicine, the ner…
Matched conditions: HEPATIC CANCER
Phase: NA • Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) • Aim: Symptom relief
Last updated May 17, 2026 00:45 UTC